Utility Menu French

National Association of Pharmacy Regulatory Authorities

Provinces French

Main navigation French


Recherchez dans la base de données des Annexes nationales de médicaments

Commencez votre recherche en utilisant le nom générique du produit :

Recherche par annexe
Réinitialiser

ATTENTION : Tous les résultats de la recherche seront tirés du « National Drug Schedules » du site Web en anglais.

Nom du médicament (en anglais) Commentaire Annexe Date
Sofosbuvir or its saltsPDL I FEB / 14
Solifenacin or its saltsPDL I DEC / 13
SomatostatinPDL I DEC / 13
SomatremPDL I DEC / 13
SomatropinPDL I DEC / 13
Sorafenib or its saltsPDL I DEC / 13
Sotalol or its saltsPDL I DEC / 13
Spectinomycin or its salts or derivativesPDL I DEC / 18
Spinosyn A and D isoformsPDL I DEC / 13
Spiramycin or its salts or derivativesPDL

For human use.

I DEC / 13
SpironolactonePDL I DEC / 13
StanozololC3 I JUN / 02
StavudinePDL I DEC / 13
StenboloneC3 I JUN / 02
StiripentolPDL I DEC / 13
Stramonium, its preparations, extracts and compounds II SEP / 98
Streptokinase as a debriding agent II SEP / 98
Streptokinase/streptodornase I SEP / 98
Streptomycin or its salts or derivativesPDL

For human use

I DEC / 18
Streptomycin or its salts or derivativesPDL

For veterinary use, including but not limited to dihydrostreptomycin

I DEC / 18
StreptozocinPDL I DEC / 13
Strontium and its salts for parenteral use II SEP / 98
Strontium bromidePDL I DEC / 13
Succinimide or its salts or derivativesPDL

Including but not limited to methsuximide, except those compounds used for decontaminating water.

I DEC / 13
Succinylcholine and its salts I SEP / 98
SucralfatePDL I SEP / 98
Sucroferric oxyhydroxidePDL I MAY / 18
SufentanilN I JUN / 02
Sugammadex or its saltsPDL I AUG / 16
Sulconazole or its saltsPDL I DEC / 13
Sulfinpyrazone or its saltsPDL I DEC / 13
Sulindac or its saltsPDL I DEC / 13
Sulphonamides or their salts or derivativesPDL

Including but not limited to Brinzolamide, succinylsulfathiazole, sulfacetamide, sulfadiazine, sulfadimethoxine, sulfadoxine, sulfaguanidine, sulfamerazine, sulfamethazine, sulfamethoxazole, sulfanilamide, sulfapyridine, sulfaquinoxaline, sulfasalazine, sulfathiazole, sulfisoxazole, sulphanilamide

I DEC / 18
Sulphones or their derivativesPDL

Including but not limited to dapsone. 

I DEC / 13
Sumatriptan or its saltsPDL I DEC / 13
Sunitinib or its saltsPDL I DEC / 13
Suprofen or its saltsPDL I DEC / 13
Sutilains II SEP / 98
SuvorexantPDL I DEC / 18
Suxamethonium chloridePDL I DEC / 13
Synthetic cannabinoid receptor type-1 agonists, their salts, derivatives, isomers, and salts of derivatives and isomersN

as listed in the schedules to the Controlled Drugs and Substances Act and the Narcotic Control Regulations

I JUL / 15
Tacrolimus or its derivativesPDL I DEC / 13
Tadalafil or its saltsPDL I DEC / 13
Tafamidis or its saltsPDL I FEB / 20
Talazoparib or its salts PDL I NOV / 19
TalbutalC2 I JUN / 02
Taliglucerase alfaPDL I JUN / 14
Tamoxifen or its saltsPDL I DEC / 13
Tamsulosin or its saltsPDL I DEC / 13
TapentadolN (3-[(1R,2R)-3-(dimethylamino)-1-ethyl-2-methylpropyl]-phenol), its salts, derivatives and isomers and salts of derivatives and isomers I JAN / 16
TazarotenePDL I DEC / 13
Tazobactam or its salts or derivativesPDL I DEC / 13
Tedizolid or its salts or derivativesPDL

Including but not limited to Tedizolid phosphate.

I MAY / 15
TeduglutidePDL I OCT / 15
TeflubenzuronPDL I DEC / 13
Tegaserod or its saltsPDL I DEC / 13
Telaprevir or its derivativesPDL I DEC / 13
TelbivudinePDL I DEC / 13
Telmisartan or its salts or derivativesPDL I DEC / 13
Telotristat or its salts or derivativesPDL I NOV / 18
Temazepam and its saltsTS I SEP / 98
Temozolomide or its saltsPDL I DEC / 13
TeniposidePDL I DEC / 13
Tenofovir or its salts or derivativesPDL

Including but not limited to: tenofovir disoproxil, tenofovir alafenamide

I DEC / 13
Tenoxicam or its saltsPDL I DEC / 13
Tepoxalin or its derivativesPDL I DEC / 13
Terazosin or its saltsPDL I DEC / 13
Terbinafine or its saltsPDL I DEC / 13
Terbutaline or its saltsPDL I DEC / 13
Terconazole or its saltsPDL I DEC / 13
Terfenadine or its saltsPDL I DEC / 13
Teriparatide or its saltsPDL I DEC / 13
Terlipressin or its saltsPDL I DEC / 13
Tesamorelin or its salts or derivativesPDL I APR / 14
TestosteroneC3 I JUN / 02
Tetanus immune globulin I FEB / 02
Tetanus toxoid II DEC / 98
Tetrabenazine or its saltsPDL I DEC / 13
TetracainePDL

when in a preparation containing an equal amount of lidocaine and recommended for topical use on the skin, in concentrations of 7% or higher

I FEB / 14
Tetracaine and its salts

for ophthalmic or parenteral use

II SEP / 98
Tetracaine and its salts for topical use on mucous membranes, except lozenges III SEP / 98
Tetracycline or its salts or derivativesPDL I DEC / 18
Tetrahydrozoline in nasal preparations for pediatric use II SEP / 98
Tetrahydrozoline. for ophthalmic use and in nasal preparations for adults U
TetrazepamTS I JUN / 02
Tezacaftor or its saltsPDL I JUL / 18
ThalidomidePDL I DEC / 13
ThebaconN I JUN / 02
Thebaine (paramorphine)N I JUN / 02
Theophylline or its saltsPDL I DEC / 13
ThiabendazolePDL

For human use

I DEC / 13
ThialbarbitalC2 I JUN / 02
ThiamylalC2 I JUN / 02
Thiethylperazine or its saltsPDL I DEC / 13
Thiobarbituric AcidC2 I JUN / 02
ThiocarlidePDL I DEC / 13
ThiofentanylN I JUN / 02
ThioguaninePDL I DEC / 13
ThiopentalC2 I JUN / 02
Thiopropazate or its saltsPDL I DEC / 13

1990 résultats


Footnotes

  • C1: Drug is in the Controlled Drugs and Substances Act and Part I of the Schedule to Part G of the Food and Drug Regulations
  • C2: Drug is in the Controlled Drugs and Substances Act and Part II of the Schedule to Part G of the Food and Drug Regulations
  • C3: Drug is in the Controlled Drugs and Substances Act and Part III of the Schedule to Part G of the Food and Drug Regulations
  • C4: drug is in the Controlled Drugs and Substances Act
  • C5: drug is in the Regulations Under CDSA
  • CR: drug has been recommended for addition to the Controlled Drugs and Substances Act
  • CR-C: drug has been recommended for addition to the Controlled Drugs and Substances Act, Part G of the Food and Drug Regulations
  • CR-N: drug has been recommend for addition to the Controlled Drugs and Substances Act, Narcotic Control Regulations
  • CR-TS: drug has been recommended for addition to the Controlled Drugs and Substances Act, Benzodiazepines and Other Targeted Substances Regulations
  • F1: drug appears in Part I of Schedule F to the Food and Drugs Act and Regulations
  • F2: drug appears in Part II of Schedule F to the Food and Drugs Act and Regulations
  • FR: drug has been recommended for addition to Schedule F to the Food and Drugs Act and Regulations ("Schedule F Recommended")
  • N: drug is in the Narcotic Control Regulations under the Controlled Drugs and Substances Act
  • NR: drug has not been reviewed by NDSAC
  • PDL: drug is in the Prescription Drug List (effective Dec. 19, 2013)
  • R: drug is in Part J of the Food and Drugs Act and listed in the Controlled Drugs and Substances Act
  • TS: drug is in the Benzodiazepines and Other Targeted Substances Regulations under the Controlled Drugs and Substances Act
  • U: drug has been reviewed by NDSAC and is unscheduled